Is immune nutrition the Holy Grail for cancer patients?
Nitenberg
G
G
Institut Gustave-Roussy, Villejuif, France.
Dechelotte
P
P
D001120:Arginine / Q000009:adverse effects / Q000627:therapeutic use; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage / Q000276:immunology; D005973:Glutamine / Q000009:adverse effects / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D007167:Immunotherapy; D007902:Length of Stay; D009369:Neoplasms / Q000276:immunology* / Q000378:metabolism / Q000628:therapy*; D009747:Nutritional Physiological Phenomena; D018529:Nutritional Support; D009952:Ornithine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
D005231:Fatty Acids, Unsaturated; D005973:Glutamine; C002118:ornithine alpha-ketoglutarate; D001120:Arginine; D009952:Ornithine